|
FDA SAYS AMENDMENT MAY LEAD TO COUNTERFEIT DRUGS
A provision passed by the House barring the FDA from spending federal money to block the importation of Rx drugs potentially could pave the way for counterfeiters to flood the U.S. market with fake products, according to the agency’s director of pharmacy affairs. This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives